Connection

Elizabeth Garrett-Mayer to Protein-Tyrosine Kinases

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Protein-Tyrosine Kinases.
Elizabeth Garrett-Mayer
Connection Strength
0.075
Protein-Tyrosine Kinases
  1. Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy. Urology. 2007 Mar; 69(3):526-31.
    View in: PubMed
    Score: 0.064
  2. A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations. Blood. 2001 Aug 01; 98(3):885-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.